ProShares Ultra NASDAQ Biotechnology
25 hedge funds and large institutions have $7.83M invested in ProShares Ultra NASDAQ Biotechnology in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 2 closing their positions.
Holders
25
Holders Change
+6
Holders Change %
+31.58%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
3
Reduced
7
Closed
2
Calls
$2.14M
Puts
$1.46M
Net Calls
+$683K
Net Calls Change
+$713K
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Simplex Trading
Chicago,
Illinois
| – | – | -1,514 | Closed |
|
|
ODG
27
O'Dell Group
Cincinnati,
Ohio
| – | – | -3 | Closed |
|
28
Wells Fargo
San Francisco,
California
| – | – | – | – |
|
|
CFGS
29
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
30
Wolverine Trading
Chicago,
Illinois
| – | – | – | – |
|